Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Other Non-Current Assets (2016 - 2026)

Collegium Pharmaceutical has reported Other Non-Current Assets over the past 11 years, most recently at $20.2 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 1828.65% year-over-year to $20.2 million; the TTM value through Dec 2025 reached $20.2 million, up 1828.65%, while the annual FY2025 figure was $20.2 million, 1828.65% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $20.2 million at Collegium Pharmaceutical, up from $1.1 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $20.2 million in Q4 2025 and troughed at $100000.0 in Q4 2022.
  • A 5-year average of $2.7 million and a median of $1.8 million in 2021 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 96.07% in 2022 and later skyrocketed 1828.65% in 2025.
  • Year by year, Other Non-Current Assets stood at $2.5 million in 2021, then plummeted by 96.07% to $100000.0 in 2022, then surged by 947.0% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then skyrocketed by 1828.65% to $20.2 million in 2025.
  • Business Quant data shows Other Non-Current Assets for COLL at $20.2 million in Q4 2025, $1.1 million in Q3 2025, and $1.0 million in Q2 2025.